# Bodo B. Beck

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bodo-b-beck/

## Facts

| Field | Value |
| --- | --- |
| Citations | 6,302 |
| Field | Kidney Stones and Urolithiasis Treatments |
| h-index | 46 |
| i10-index | 95 |
| Last Known Institution | University of Cologne |
| OpenAlex ID | https://openalex.org/A5077812685 |
| ORCID iD | 0000-0003-0495-7670 |
| Works | 193 |

## Researcher papers

- [The primary hyperoxalurias](https://scholariq.org/papers/the-primary-hyperoxalurias/)
- [Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy](https://scholariq.org/papers/early-angiotensin-converting-enzyme-inhibition-in-alport-syndrome-delays-renal/)
- [Bone Mineral Content per Muscle Cross-Sectional Area as an Index of the Functional Muscle-Bone Unit](https://scholariq.org/papers/bone-mineral-content-per-muscle-cross-sectional-area-as-an-index-of-the/)
- [ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling](https://scholariq.org/papers/arhgdia-mutations-cause-nephrotic-syndrome-via-defective-rho-gtpase-signaling/)
- [Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1](https://scholariq.org/papers/oxalobacter-formigenes-a-potential-tool-for-the-treatment-of-primary/)
- [Polyhydramnios, Transient Antenatal Bartter’s Syndrome, and<i>MAGED2</i>Mutations](https://scholariq.org/papers/polyhydramnios-transient-antenatal-bartter-s-syndrome-and-i-maged2-i-mutations/)
- [Nephrocalcinosis and urolithiasis in children](https://scholariq.org/papers/nephrocalcinosis-and-urolithiasis-in-children/)
- [A molecular mechanism explaining albuminuria in kidney disease](https://scholariq.org/papers/a-molecular-mechanism-explaining-albuminuria-in-kidney-disease/)
- [Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope](https://scholariq.org/papers/clinical-practice-recommendations-for-primary-hyperoxaluria-an-expert-consensus/)
- [Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid–Resistant Nephrotic Syndrome](https://scholariq.org/papers/rapid-response-to-cyclosporin-a-and-favorable-renal-outcome-in-nongenetic-versus/)
- [Lifelong effect of therapy in young patients with the <i>COL4A5</i> Alport missense variant p.(Gly624Asp): a prospective cohort study](https://scholariq.org/papers/lifelong-effect-of-therapy-in-young-patients-with-the-i-col4a5-i-alport-missense/)

## Researcher topics

- [Kidney Stones and Urolithiasis Treatments](https://scholariq.org/topics/kidney-stones-and-urolithiasis-treatments/)
- [Biomedical Research and Pathophysiology](https://scholariq.org/topics/biomedical-research-and-pathophysiology/)
- [Porphyrin Metabolism and Disorders](https://scholariq.org/topics/porphyrin-metabolism-and-disorders/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Pediatric Urology and Nephrology Studies](https://scholariq.org/topics/pediatric-urology-and-nephrology-studies/)

## Researcher university

- [University of Cologne](https://scholariq.org/institutions/university-of-cologne/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.